Document is current
Any future updates will be listed below
-
Authors
Sánchez-Fernández, Alba
Zandee, Stephanie
Mastrogiovanni, Mauricio
Charabati, Marc
Rubbo, Homero
Prat, Alexandre
López-Vales, Rubèn
-
Funding
Funding for this research was provided by:
Ministerio de Economia y Competitividad (SAF2016-79774-R)
Wings for Life
“la Caixa” Foundation (LCF/PR/HA17/52170001)
Ministerio de Ciencia, Innovación y Universidades (PID2020-120267RB-I00)
- License Information
-
More Information
Article History
Received: 17 September 2021
Accepted: 13 January 2022
First Online: 2 February 2022
Declarations
:
: Tissue samples were collected from MS patients with full ethical approval (BH07.001) and informed consent was approved by the local ethics committee in Montreal (Canada). All experimental procedures were approved by the Universitat Autònoma de Barcelona Animal Experimentation Ethical Committee (CEEAH 2878) and followed the European Communities Council Directive 2010/63/EU, and the methods were carried out in accordance with the approved guidelines.
: Not applicable.
: A.S.-F and R.L.-V. are inventors on a patent application filled by Universitat Autònoma de Barcelona “Specialized pro-resolving lipid mediators for use in the treatment of neurodegenerative diseases and/or autoimmune diseases” (PCT EP2018/051076). The remaining authors declare no competing financial interests.
